GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (FRA:2BO) » Definitions » Change In Other Working Capital

Serina Therapeutics (FRA:2BO) Change In Other Working Capital : €-0.18 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Change In Other Working Capital?

Serina Therapeutics's Change In Other Working Capital for the quarter that ended in Mar. 2025 was €-0.05 Mil. It means Serina Therapeutics's Other Working Capital declined by €0.05 Mil from Dec. 2024 to Mar. 2025 .

Serina Therapeutics's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was €-0.21 Mil. It means Serina Therapeutics's Other Working Capital declined by €0.21 Mil from Dec. 2023 to Dec. 2024 .


Serina Therapeutics Change In Other Working Capital Historical Data

The historical data trend for Serina Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Change In Other Working Capital Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
-1.46 -0.01 -0.17 -0.21

Serina Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.05 -0.03 -0.05 -0.05 -0.05

Serina Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Serina Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Serina Therapeutics Business Description

Traded in Other Exchanges
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Serina Therapeutics Headlines

No Headlines